The Tumor Immune Microenvironment in Breast Cancer Progression
Marit Otterlei Fjørtoft1, Kanutte Huse2, Inga Hansine Rye3
1Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Oslo University Hospital, Radium Hospital, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Breast cancer progression involves complex immune cell interactions. Higher immune infiltration in triple-negative and HER2+ subtypes correlates with better survival, while ER+ tumors show poorer outcomes.
Area of Science:
- Oncology
- Immunology
- Cancer Biology
Background:
- The tumor microenvironment critically impacts breast cancer development, progression, and metastasis.
- Immune cells like T cells, B cells, NK cells, and myeloid cells play varied roles, supporting or hindering anti-tumor responses across breast cancer subtypes.
Purpose of the Study:
- To review predominant immune cell populations in breast cancer subtypes.
- To elucidate the suppressive and prognostic effects of immune cells.
- To outline the immune microenvironment's role from normal tissue to metastasis.
Main Methods:
- A comprehensive literature review was performed.
- Analysis focused on immune cell involvement throughout breast cancer progression.
Main Results:
- Breast tumors show increased immune cell infiltration compared to normal tissue.
- Triple-negative and HER2+ breast cancers exhibit higher immune infiltration linked to better survival.
- Estrogen receptor-positive (ER+) tumors have lower immune infiltration, associated with poorer outcomes, and metastatic sites often present a more immunosuppressive environment.
Conclusions:
- Understanding tumor-immune cell interactions is crucial for advancing breast cancer research.
- This knowledge is essential for developing effective immune-based therapies and improving patient outcomes.
More Related Videos
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018
Related Concept Videos
The Tumor Microenvironment
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
